ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Anti-ERK8 (Phospho-Thr175 / Tyr177) Antibody (A50718)

This product is discontinued

Anti-ERK8 (Phospho-Thr175 / Tyr177) Antibody (A50718) has been discontinued and is no longer available.

View all ERK8 Antibodies.

Name
Anti-ERK8 (Phospho-Thr175 / Tyr177) Antibody
Description
Rabbit polyclonal antibody to ERK8 (Phospho-Thr175 / Tyr177)
Specificity
The antibody detects endogenous levels of ERK8 only when phosphorylated at threonine 175 and tyrosine 177.
Applications
WB
Reactivity
Human, Mouse
Immunogen
Peptide sequence around phosphorylation site of threonine 175 and tyrosine 177 (A-V-T(p)-E-Y(p)-V-A) derived from Human ERK8.
Host
Rabbit
Clonality
Polyclonal
Conjugate

Unconjugated

Purification
Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy using non-phosphopeptide.
Concentration
1.0 mg/mL
Formulation
Supplied in phosphate-buffered saline (without Mg²? and Ca²?), pH 7.4, containing 150 mM NaCl, 0.02% sodium azide, and 50% glycerol.
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Synonyms
ERK-7, ERK-8, ERK7, Extracellular signal-regulated kinase 7, Extracellular signal-regulated kinase 8, MAP kinase 15, MAPK 15, Mitogen-activated protein kinase 15
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.

Alternative products to Anti-ERK8 (Phospho-Thr175 / Tyr177) Antibody (A50718)

Proteins predicted to interact with MAPK15

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
97.7% Relevancy Score
83.9% Relevancy Score
74.3% Relevancy Score
73.6% Relevancy Score
68.4% Relevancy Score
65.4% Relevancy Score
61.2% Relevancy Score
53.8% Relevancy Score
53.1% Relevancy Score